Medical Doctor Program year 2023 Reported 2019–2023 Source: CMS Open Payments, 2026 publication

Avery Arora

Surgery of the Hand West Bloomfield, MI Medical Doctor

NPI 1932313558 CMS profile 930934

7001 Orchard Lake Rd Ste 220, West Bloomfield, MI 48322

Open in the dashboard

General payments

$7,358

28 records reported · program years 2019–2023

Research payments

$0

Paid to them · None reported · program years 2019–2023

Ownership & investment interest

$0

None reported

Through program year 2023, Avery Arora of West Bloomfield, MI is reported in the CMS Open Payments database as having received $7,358 across 28 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 78th percentile of Surgery of the Hand profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2023 General $31 2
2022 General $4,841 14
2021 General $1,222 3
2020 General $57 4
2019 General $1,206 5

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Avery Arora
  • Surgery of the Hand median
  • Middle half of Surgery of the Hand
  • National median

In program year 2025, general payments to Avery Arora were reported at $0. Among 286 Surgery of the Hand profiles paid that year, the median was $288 and the middle half received between $115 and $1,242.

Show as a table
Year Avery Arora Surgery of the Hand median Middle half National median
2019 $1,206 $369 $108–$1,516 $163
2020 $57 $153 $56–$898 $114
2021 $1,222 $261 $84–$1,296 $132
2022 $4,841 $313 $103–$1,562 $149
2023 $31 $241 $95–$876 $160
2024 $0 $236 $84–$890 $164
2025 $0 $288 $115–$1,242 $169

Breakdown

Who paid General payments · program years 2019–2023
  1. Endo Pharmaceuticals Inc. $4,883 16 payments
  2. Pinnacle, Inc $1,909 4 payments
  3. Wright Medical Technology, Inc. $467 1 payment
  4. Boston Scientific Corporation $43 3 payments
  5. Bioventus LLC $29 2 payments
  6. Horizon Therapeutics plc $14 1 payment
  7. Orthofix Medical, Inc. $13 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2023
  1. Consulting Fee $3,400 1 payment
  2. Education $1,900 2 payments
  3. Travel and Lodging $1,236 6 payments
  4. Gift $467 1 payment
  5. Food and Beverage $355 18 payments
Products named General payments · program years 2019–2023
  1. XIAFLEX $4,883 16 payments
  2. AEQUALIS $467 1 payment
  3. General - Pain Management $30 2 payments
  4. Exogen $29 2 payments
  5. DUEXIS $14 1 payment
  6. Physio-Stim Osteogenesis Stimulator $13 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 2 drugs

Part D claims

48

Median for Hand Surgery: 118

Drug cost

$177

Median for Hand Surgery: $615

Branded share of claims

0%

Median for Hand Surgery: 34.5%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Methylprednisolone Generic 32 $162
Tramadol Hcl Generic 16 $14

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 1,399 Part D prescribers listed as Hand Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 54 billing codes

Paid by Medicare

$161,623

Of which drugs: $51,146

Medicare patients

266

Average age 73

Services billed

2,436

158 women, 108 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 74%
Arthritis 71%
Ischemic heart disease 33%
Diabetes 29%
Depression 21%
Chronic kidney disease 20%
COPD 15%
Atrial fibrillation 14%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg J0702 Office 71 107 $573
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 39 292 $226
Injection, lidocaine hcl for intravenous infusion, 10 mg J2001 Office 77 139 $3

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

28 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Surgery of the Hand in Michigan

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2023

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record